Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair.

Proc Natl Acad Sci U S A

Laboratory for Skin Cancer Research, Hospital Research Centre of Laval University (CHUL) and Centre Hospitalier Universitaire du Quebec (CHUQ), Laval University, Quebec, QC, Canada G1V 4G2.

Published: January 2013

Among the earliest responses of mammalian cells to DNA damage is catalytic activation of a nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1). Activated PARP-1 forms the polymers of ADP-ribose (pADPr or PAR) that posttranslationally modify its target proteins, such as PARP-1 and DNA repair-related proteins. Although this metabolism is known to be implicated in other repair pathways, here we show its role in the versatile nucleotide excision repair pathway (NER) that removes a variety of DNA damages including those induced by UV. We show that PARP inhibition or specific depletion of PARP-1 decreases the efficiency of removal of UV-induced DNA damage from human skin fibroblasts or mouse epidermis. Using NER-proficient and -deficient cells and in vitro PARP-1 assays, we show that damaged DNA-binding protein 2 (DDB2), a key lesion recognition protein of the global genomic subpathway of NER (GG-NER), associates with PARP-1 in the vicinity of UV-damaged chromatin, stimulates its catalytic activity, and is modified by pADPr. PARP inhibition abolishes UV-induced interaction of DDB2 with PARP-1 or xeroderma pigmentosum group C (XPC) and also decreases localization of XPC to UV-damaged DNA, which is a key step that leads to downstream events in GG-NER. Thus, PARP-1 collaborates with DDB2 to increase the efficiency of the lesion recognition step of GG-NER.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562836PMC
http://dx.doi.org/10.1073/pnas.1209507110DOI Listing

Publication Analysis

Top Keywords

polyadp-ribose polymerase-1
8
removal uv-induced
8
uv-induced dna
8
nucleotide excision
8
excision repair
8
dna damage
8
parp-1
8
parp inhibition
8
lesion recognition
8
dna
6

Similar Publications

A Cyclometalated Ruthenium(II) Complex Induces Oncosis for Synergistic Activation of Innate and Adaptive Immunity.

Angew Chem Int Ed Engl

July 2024

MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, School of Chemistry, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510006, P. R. China.

Article Synopsis
  • An effective cancer chemotherapy should tackle tumor drug resistance while also triggering the body's immune response against cancer cells.
  • The study introduces a synthesized Ru(II) complex that induces oncosis by damaging nuclear and mitochondrial DNA, activating cell death pathways, and leading to cell membrane rupture.
  • Experimental results show that the Ru(II) complex stimulates both innate and adaptive immune responses, enhancing dendritic cell maturation and promoting the activation of cytotoxic T lymphocytes and M1 macrophages.
View Article and Find Full Text PDF

Treating Traumatic Brain Injury with Minocycline.

Neurotherapeutics

October 2023

Graduate Programs in Neural and Behavioral Sciences, State University of New York Downstate Health Sciences University, 450 Clarkson Avenue, Brooklyn, New York, NY, 11203, USA.

Traumatic brain injury (TBI) results in both rapid and delayed brain damage. The speed, complexity, and persistence of TBI present large obstacles to drug development. Preclinical studies from multiple laboratories have tested the FDA-approved anti-microbial drug minocycline (MINO) to treat traumatic brain injury.

View Article and Find Full Text PDF

DDI2 promotes tumor metastasis and resists antineoplastic drugs-induced apoptosis in colorectal cancer.

Apoptosis

April 2023

Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Taibai North Road 229, Xi'an, 710069, Shaanxi, China.

The normal colorectal mucosa undergoes precancerous lesions that can develop over time into colorectal cancer (CRC). In the stage of precancerous lesions, DNA replication stress may lead to genome instability. We have performed whole-exome sequencing on genomic DNA obtained from three cases of CRC tissues and identified a novel frameshift mutation of DNA damage inducible 1 homolog 2 gene (DDI2, c.

View Article and Find Full Text PDF

The Oxidative Damage and Inflammation Mechanisms in GERD-Induced Barrett's Esophagus.

Front Cell Dev Biol

May 2022

Department of General Surgery, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing, China.

Barrett's esophagus is a major complication of gastro-esophageal reflux disease and an important precursor lesion for the development of Barrett's metaplasia and esophageal adenocarcinoma. However, the cellular and molecular mechanisms of Barrett's metaplasia remain unclear. Inflammation-associated oxidative DNA damage could contribute to Barrett's esophagus.

View Article and Find Full Text PDF

Better together? Treating traumatic brain injury with minocycline plus N-acetylcysteine.

Neural Regen Res

December 2022

Graduate Program in Neural and Behavioral Sciences; Department of Physiology and Pharmacology, State University of New York-Downstate Health Sciences University, Brooklyn, NY, USA.

Traumatic brain injury has a complex pathophysiology that produces both rapid and delayed brain damage. Rapid damage initiates immediately after injury. Treatment of traumatic brain injury is typically delayed many hours, thus only delayed damage can be targeted with drugs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!